CNS vs GATX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

CNS

43.0
AI Score
VS
CNS Wins

GATX

37.6
AI Score

Investment Advisor Scores

CNS

43score
Recommendation
HOLD

GATX

38score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric CNS GATX Winner
Forward P/E 18.5874 19.084 CNS
PEG Ratio 1.3563 0.6428 GATX
Revenue Growth 11.1% 36.1% GATX
Earnings Growth 0.0% 29.8% GATX
Tradestie Score 43.0/100 37.6/100 CNS
Profit Margin 28.2% 17.7% CNS
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY CNS

Relative Price Performance (Last 90 Days)

CNS 1M: +5.6% · 3M: -15.1% GATX 1M: +12.6% · 3M: +4.7%

Current Technical Phase

CNS

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -5.6%) with fading momentum, RSI 50

RSI (14): 49.8 · Price: $72.72

GATX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 64

RSI (14): 63.5 · Price: $187.67

Fundamentals Snapshot

Metric CNS GATX
Market Cap — —
Forward P/E 19.6 16.6
Trailing P/E 22.7 17.4
Revenue (TTM) — —
Revenue Growth 0.1% 0.4%
Gross Margin 0.5% 0.7%
Operating Margin 0.3% 0.3%
EPS 3.25 10.77
Dividend Yield 0.04% 0.01%

Frequently Asked Questions

Based on our detailed analysis, CNS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.